input: {"date":"2020-12-24","features":{"asof_close":23241.345703125,"ret_1d":-0.022776055438033516,"ret_7d":0.09060037067091575,"ret_30d":0.26558442870619614,"ma_5":23434.916796875,"ma_20":20531.3884765625,"ma5_gt_ma20":true,"rsi_14":68.0466452386288,"vol_20_annualized":0.5557086479634759,"gold":1879.9000244140625,"oil":48.22999954223633,"hash_rate":116940488.24665588,"difficulty":18670168558400.0,"n_transactions":269559.0,"n_unique_addresses":639280.0,"fng":0.86,"cbbi":0.71,"market_cap":425949198918.75006,"total_supply":18579712.5,"est_tx_volume_usd":4019021845.006808,"news_snippets":["Digital asset manager Grayscale Investments reached $16.4 billion in assets under management (AUM), up from the $13 billion the firmannouncedlast week. • Datatweetedby the firm showed its largest holdings remain inbitcoi…","Digital asset manager Grayscale Investments reached $16.4 billion in assets under management (AUM), up from the $13 billion the firm announced last week. Data tweeted by the firm showed its largest holdings remain in bit…","VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / HIVE Blockchain Technologies Ltd. (TSX.V:HIVE)(OTCQX:HVBTF)(FSE:HBF) (the &ldquo;Company&rdquo; or &ldquo;HIVE&rdquo;) is pleased to announce, subject to regulatory approv…","VANCOUVER, BC / ACCESSWIRE / December 24, 2020 /HIVE Blockchain Technologies Ltd. (TSX.V:HIVE)(OTCQX:HVBTF)(FSE:HBF) (the &ldquo;Company&rdquo; or &ldquo;HIVE&rdquo;) is pleased to announce, subject to regulatory approva…","AUD/USD Video 24.12.20. Australian Dollar Continues To Move Higher Against U.S. Dollar AUD/USD is testing the resistance at 0.7600 while the U.S. dollar remains under pressure against a broad basket of currencies. The U.…","AUD/USD Video 24.12.20. AUD/USDis testing the resistance at 0.7600 while the U.S. dollar remains under pressure against a broad basket of currencies. The U.S. Dollar Index is currently trying to get below the support at…"],"tweet_snippets":[],"context_article":["Sanofi SA (NASDAQ: SNY ) and GlaxoSmithKline plc (NYSE: GSK ) on Friday reported a delay in their COVID-19 vaccine program as interim results from Phase 1 and 2 trials indicate a low immune response in older adults. What Happened: The drugmakers said in a stat…"]}}